Mebius Pharmaceutical Co., Ltd – Trademark Portfolio
Entity Type: 03
Mebius Pharmaceutical Co., Ltd holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 3 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include SIMIUS and MEBIUS PHARMACEUTICAL CO., LTD.
Sumitomo Fudosan Roppongi Grand Tower
43F, 3-2-1, Roppongi, Minato-ku Tokyo 106-6243
Showing of trademarks Trademarks
Trademark Classifications
Mebius Pharmaceutical Co., Ltd's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Mebius Pharmaceutical Co., Ltd have?
Mebius Pharmaceutical Co., Ltd has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.
What trademark classes does Mebius Pharmaceutical Co., Ltd file in?
Mebius Pharmaceutical Co., Ltd files trademarks across 2 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.
What are Mebius Pharmaceutical Co., Ltd's most well-known trademarks?
Mebius Pharmaceutical Co., Ltd's registered trademark portfolio includes well-known marks such as SIMIUS and MEBIUS PHARMACEUTICAL CO., LTD. These are among 3 currently registered trademarks in the portfolio.
What is Mebius Pharmaceutical Co., Ltd's trademark registration success rate?
Mebius Pharmaceutical Co., Ltd has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.